A Plasmacytoid Variant of Urothelial Carcinoma: A Rare Entity

A rare histological variant of transitional cell urothelial carcinoma, the plasmacytoid variant, was recently included in the World Health Organization classification of urothelial tract tumors. This variant has a morphological resemblance to other tumors, which poses a diagnostic challenge for identifying this tumor and may often lead to misdiagnosis. Vigilant histopathological analysis and immunostaining are required to delineate the correct diagnosis. The plasmacytoid variant of urothelial carcinoma is an aggressive tumor with a poor prognosis, making correct diagnosis essential for early and appropriate treatment. This paper presents the case of a 46-year-old male with a plasmacytoid variant of high-grade urothelial carcinoma who underwent transurethral resection of a bladder tumor, received chemotherapy, and is currently undergoing follow-up.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-08-21
DOI
https://doi.org/10.7759/cureus.67436
Citations
2
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
1.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Plasmacytoid Variant of Urothelial Carcinoma: A Rare Entity

Maryam Imran, Muhammad Awais Majeed, Muhammad Ahsan Jamil, Midhat Waheed et al.
2 citations
Cureus
Bladder and Urothelial Cancer Treatments
1.15
article

A Plasmacytoid Variant of Urothelial Carcinoma: A Rare Entity

Maryam Imran, Muhammad Awais Majeed, Muhammad Ahsan Jamil, Midhat Waheed, Ammara Yasmin
article en
2 citations

Abstract

A rare histological variant of transitional cell urothelial carcinoma, the plasmacytoid variant, was recently included in the World Health Organization classification of urothelial tract tumors. This variant has a morphological resemblance to other tumors, which poses a diagnostic challenge for identifying this tumor and may often lead to misdiagnosis. Vigilant histopathological analysis and immunostaining are required to delineate the correct diagnosis. The plasmacytoid variant of urothelial carcinoma is an aggressive tumor with a poor prognosis, making correct diagnosis essential for early and appropriate treatment. This paper presents the case of a 46-year-old male with a plasmacytoid variant of high-grade urothelial carcinoma who underwent transurethral resection of a bladder tumor, received chemotherapy, and is currently undergoing follow-up.

CureusVol. 16(8)
Shaukat Khanum Memorial Cancer Hospital and Research Center (PK)
Good health and well-being
Openalex Percentile: Top 21%
Bladder and Urothelial Cancer Treatments
1.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.